203 related articles for article (PubMed ID: 11829733)
1. A review of pramipexole and its clinical utility in Parkinson's disease.
Biglan KM; Holloway RG
Expert Opin Pharmacother; 2002 Feb; 3(2):197-210. PubMed ID: 11829733
[TBL] [Abstract][Full Text] [Related]
2. Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
Dooley M; Markham A
Drugs Aging; 1998 Jun; 12(6):495-514. PubMed ID: 9638397
[TBL] [Abstract][Full Text] [Related]
3. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
Parkinson Study Group
JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
[TBL] [Abstract][Full Text] [Related]
4. Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease.
Radad K; Gille G; Rausch WD
Pharmacol Rep; 2005; 57(6):701-12. PubMed ID: 16382188
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. Parkinson Study Group.
JAMA; 1997 Jul; 278(2):125-30. PubMed ID: 9214527
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Parkinson Study Group.
Clin Neuropharmacol; 2000; 23(1):34-44. PubMed ID: 10682229
[TBL] [Abstract][Full Text] [Related]
7. Dopamine agonist monotherapy in Parkinson's disease.
Clarke CE; Guttman M
Lancet; 2002 Nov; 360(9347):1767-9. PubMed ID: 12480442
[TBL] [Abstract][Full Text] [Related]
8. Ropinirole and pramipexole, the new agonists.
Hobson DE; Pourcher E; Martin WR
Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S27-33. PubMed ID: 10451757
[TBL] [Abstract][Full Text] [Related]
9. [Pramipexole in Parkinson disease. Results of a treatment observation].
Reichmann H; Brecht HM; Kraus PH; Lemke MR
Nervenarzt; 2002 Aug; 73(8):745-50. PubMed ID: 12242961
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease: a meta-analysis.
Etminan M; Gill S; Samii A
Drug Saf; 2003; 26(6):439-44. PubMed ID: 12688834
[TBL] [Abstract][Full Text] [Related]
11. Dopamine agonists and neuroprotection in Parkinson's disease.
Schapira AH
Eur J Neurol; 2002 Nov; 9 Suppl 3():7-14. PubMed ID: 12464116
[TBL] [Abstract][Full Text] [Related]
12. The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease.
Molho ES; Factor SA; Weiner WJ; Sanchez-Ramos JR; Singer C; Shulman L; Brown D; Sheldon C
J Neural Transm Suppl; 1995; 45():225-30. PubMed ID: 8748629
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
Etminan M; Samii A; Takkouche B; Rochon PA
Drug Saf; 2001; 24(11):863-8. PubMed ID: 11665873
[TBL] [Abstract][Full Text] [Related]
14. Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison.
Inzelberg R; Schechtman E; Nisipeanu P
Drugs Aging; 2003; 20(11):847-55. PubMed ID: 12964891
[TBL] [Abstract][Full Text] [Related]
15. DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S93-7. PubMed ID: 12211148
[No Abstract] [Full Text] [Related]
16. Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease.
Wong KS; Lu CS; Shan DE; Yang CC; Tsoi TH; Mok V
J Neurol Sci; 2003 Dec; 216(1):81-7. PubMed ID: 14607306
[TBL] [Abstract][Full Text] [Related]
17. Non-ergot dopamine agonist-induced sleep attacks.
Ryan M; Slevin JT; Wells A
Pharmacotherapy; 2000 Jun; 20(6):724-6. PubMed ID: 10853628
[TBL] [Abstract][Full Text] [Related]
18. Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.
Bennett JP; Piercey MF
J Neurol Sci; 1999 Feb; 163(1):25-31. PubMed ID: 10223406
[TBL] [Abstract][Full Text] [Related]
19. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease.
Kujawa K; Leurgans S; Raman R; Blasucci L; Goetz CG
Arch Neurol; 2000 Oct; 57(10):1461-3. PubMed ID: 11030798
[TBL] [Abstract][Full Text] [Related]
20. Pramipexole in patients with early Parkinson's disease.
Hubble JP; Koller WC; Cutler NR; Sramek JJ; Friedman J; Goetz C; Ranhosky A; Korts D; Elvin A
Clin Neuropharmacol; 1995 Aug; 18(4):338-47. PubMed ID: 8665547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
